The Antirust Bulletin Vol 59, No. 3/Fall2014 is out

Volume 59, Number 3/Fall 2014

The Antitrust Bulletin Journal of Antitrust Law and Trade Regulation

---

SYMPOSIUM: IMPLICATIONS OF RECENT MERGER LITIGATION FOR MARKET DEFINITION       Malcolm B. Coate and Kent Bernard, Guest Editors

---

 

Introduction        By Malcolm B. Coate and Kent Bernard

HOSPITAL MERGERS—ARTICLES & COMMENTS

From Rockford to Joplin and Back Again: The Impact of Economics on Hospital Merger Enforcement       By Cory S. Capps

Unresolved Questions Relating to Market Definition in Hospital Mergers       By Sean May and Monica Noether

Competitive Effects Analyses of Hospital Mergers: AreWe Keeping Pace with Dynamic Healthcare Markets?       By Margaret E. Guerin-Calvert

The Importance of Substitution in Assessing Health Care Provider Mergers       By Brett W. Wendling and Nathan E. Wilson

LUNDBECK:APRESCRIPTION DRUG MERGER—ARTICLES & COMMENTS

When the Price Isn’t Right – The Lundbeck Case and a Path to Analyze Competition in Drug Research and Development       By Kent Bernard

FTC v. Lundbeck: Is Anything in Antitrust Obvious, Like, Ever? By Chris Sagers and Richard M. Brunell

Nonprice Competition in “Substitute” Drugs: The FTC’s Blind Spot       By Gregory Dolin, M.D.

Predicting Competitive Effects From Prescription Drug Mergers: How Standard Economic Analysis Can Go Wrong       By Gregory J. Werden

H&R BLOCK: AMERGER IN A CONSUMER GOOD—ARTICLES

United States v. H&R Block: Market Definition in Court Since the 2010 Merger Guidelines       By Marc Remer and Frederick R. Warren-Boulton

Market Definition in Differentiated GoodsWhen the Final Consumer Buys the Good: Insights from the H&R Block Case       By Malcolm B. Coate

POLYPORE: AMERGER IN A PRODUCER GOOD—ARTICLES

Market Power in Battery Separators: In re Polypore       By John Simpson and J. Robert Robertson Market Definition—Achieving an Integrated Analysis       By Henry J. Kahwaty and Cleve B. Tyler